KE3526A - Androstane carbothioates - Google Patents

Androstane carbothioates

Info

Publication number
KE3526A
KE3526A KE3526A KE352685A KE3526A KE 3526 A KE3526 A KE 3526A KE 3526 A KE3526 A KE 3526A KE 352685 A KE352685 A KE 352685A KE 3526 A KE3526 A KE 3526A
Authority
KE
Kenya
Prior art keywords
group
alpha
compounds
hydrogen
formula
Prior art date
Application number
KE3526A
Inventor
Hanley Phillipps Gordon
Macdonald Bain Brian
Williamson Christopher
Philip Steeples Ian
Bruce Laing Stuart
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of KE3526A publication Critical patent/KE3526A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Compounds of the formula <IMAGE> in which R<1> is a fluoro-, chloro- or bromomethyl group or a 2'-fluoroethyl group, R<2> is a group COR<6> in which R<6> is a C1-3-alkyl group, or OR<2> and R<3> together form a 16 alpha ,17 alpha -isopropylidenedioxy group; R<3> is a hydrogen atom, a methyl group (which can be present in either the alpha or the ss configuration) or a methylene group; R<4> is a hydrogen, chlorine or fluorine atom; R<5> is a hydrogen or fluorine atom, and the symbol ..... is a single or double bond. The compounds have good anti-inflammatory activity, in particular on topical application. The compounds of the formula I are prepared by esterification, halogenation, reduction, elimination of protective groups and reaction at a 9,11 double bond to form a 9 alpha -halo-11ss-hydroxy group.
KE3526A 1980-02-15 1985-05-13 Androstane carbothioates KE3526A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8005174 1980-02-15
GB8013339 1980-04-23

Publications (1)

Publication Number Publication Date
KE3526A true KE3526A (en) 1985-06-07

Family

ID=26274505

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3526A KE3526A (en) 1980-02-15 1985-05-13 Androstane carbothioates

Country Status (23)

Country Link
KR (1) KR850000969B1 (en)
AT (1) AT395427B (en)
AU (1) AU544517B2 (en)
BG (1) BG60700B2 (en)
CH (2) CH651307A5 (en)
CZ (1) CZ281275B6 (en)
DE (2) DE3153379C2 (en)
DK (1) DK147022C (en)
ES (5) ES8207194A1 (en)
FI (1) FI70904C (en)
FR (2) FR2477156A1 (en)
HK (1) HK58385A (en)
IE (1) IE51394B1 (en)
IT (1) IT1170717B (en)
KE (1) KE3526A (en)
MX (1) MX9202717A (en)
MY (1) MY8500757A (en)
NL (2) NL191792C (en)
NZ (1) NZ196260A (en)
PT (1) PT72502B (en)
SE (1) SE452468B (en)
SG (1) SG36885G (en)
SK (1) SK403491A3 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436549A (en) * 1972-06-15 1976-05-19 Glaxo Lab Ltd 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB1580517A (en) * 1978-04-06 1980-12-03 Fowler I Crutches

Also Published As

Publication number Publication date
CH651307A5 (en) 1985-09-13
FR2477156B1 (en) 1984-11-16
ES524985A0 (en) 1985-01-01
FR2477156A1 (en) 1981-09-04
KR850000969B1 (en) 1985-07-02
NL191792B (en) 1996-04-01
ATA67481A (en) 1992-05-15
NL960029I1 (en) 1997-02-03
ES8402317A1 (en) 1984-01-16
FR2485542B1 (en) 1983-06-10
DK62381A (en) 1981-08-16
AU6729881A (en) 1981-08-20
IE51394B1 (en) 1986-12-24
ES8305379A1 (en) 1983-04-01
BG60700B2 (en) 1995-12-29
DE3153379C2 (en) 1992-11-19
NL8100707A (en) 1981-09-16
PT72502B (en) 1982-02-05
MY8500757A (en) 1985-12-31
ES509539A0 (en) 1983-04-01
ES518161A0 (en) 1984-01-16
KR830005262A (en) 1983-08-03
DE3105307A1 (en) 1981-12-10
AU544517B2 (en) 1985-06-06
ES532055A0 (en) 1985-10-16
IE810282L (en) 1981-08-15
DK147022C (en) 1984-08-27
AT395427B (en) 1992-12-28
NL960029I2 (en) 1997-04-01
ES499394A0 (en) 1982-09-01
SK278140B6 (en) 1996-02-07
ES8207194A1 (en) 1982-09-01
ES8502447A1 (en) 1985-01-01
DK147022B (en) 1984-03-19
ES8600936A1 (en) 1985-10-16
SK403491A3 (en) 1996-02-07
SG36885G (en) 1985-11-15
FI810444L (en) 1981-08-16
IT8147792A0 (en) 1981-02-13
IT1170717B (en) 1987-06-03
FR2485542A1 (en) 1981-12-31
NL191792C (en) 1996-08-02
SE452468B (en) 1987-11-30
PT72502A (en) 1981-03-01
MX9202717A (en) 1992-06-30
SE8101010L (en) 1981-08-16
CH644615A5 (en) 1984-08-15
CZ281275B6 (en) 1996-08-14
FI70904B (en) 1986-07-18
FI70904C (en) 1986-10-27
NZ196260A (en) 1983-11-30
DE3105307C2 (en) 1988-09-29
CZ403491A3 (en) 1994-03-16
HK58385A (en) 1985-08-16

Similar Documents

Publication Publication Date Title
DK159757C (en) APPLICATION OF NAPHTHALENDER DERIVATIVES FOR THE PREPARATION OF A MEDICINE FOR TREATMENT OR PROPHYLACY OF INFLAMMATION BY TOPIC ADMINISTRATION AND PHARMACEUTICAL PREPARATION FOR TOPICAL USE CONTAINING NAPHTHREEN
ES8701733A1 (en) Redox indicators.
ES8608535A1 (en) Pharmaceutical composition.
ES8300785A1 (en) Androstene 17 alpha -carbonate 17 beta -carboxylates (and carbothioates)
JPS5366442A (en) Antitumors
FI842815A0 (en) FOERENING OCH KOMPOSITION FOER THERAPEUTIC ELLER DIAGNOSTIC ANVAENDNING OCH THERAPEUTIC BEHANDLINGSMETOD.
ES8101530A1 (en) beta , gamma -Dihydropolyprenyl alcohol and hypotensive pharmaceutical composition containing same
SG36885G (en) Androstane carbothioates
JPS57206610A (en) Anti-inflammatory analgesic solution for external use
FR2433553A1 (en) RESINS OF UNSATURATED POLYESTERS, NOT INHIBITED BY AIR OXYGEN, THEIR PREPARATION AND THEIR USES
JPS5422331A (en) Preparation of quinones
JPS51143039A (en) An adhesive composition
JPS54125620A (en) Preparation of diazomethane derivative
JPS5742643A (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol
GB1310741A (en) Anthraquinone dyestuffs
SE7904080L (en) TERMINAL-BIFUNCTIONAL XYLITE DERIVATIVES
JPS5430108A (en) Diyne-type polyprenyl alcohol and hypotensive agent containing the same
ES453829A1 (en) Procedure for preparation of quinazolinones (Machine-translation by Google Translate, not legally binding)
JPS548642A (en) Improvement in anticorrosion of electrodeposit coating film
JPS5490145A (en) 4-chloromethylsulfonyl-2,6-dinitrohalogenobenzene derivative, and algicide containing the same
EP0143381A3 (en) Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom
JPS5675429A (en) Anti-inflammatory agent containing ethyl piperidylacetylaminobenzoate
JPS5429327A (en) Bispiropirazine compound, its preparation, and its use as pigment